Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00013026 · ClinicalTrials.gov registry record · NA

Trial of a Tailored Message Program to Implement CHF Guidelines

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
700
Enrollment target

NCT00013026: Completed NA study, sponsored by US Department of Veterans Affairs.

NCT00013026 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 700 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00013026, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
700 participants
Enrollment target

Study Summary

Congestive heart failure is a serious health problem in the United States and is associated with excessive morbidity and mortality. Several classes of medications have been shown to improve mortality in patients with CHF. Despite this these medications are widely under prescribed. Guidelines have been shown to improve patient outcomes and several guidelines on the management of CHF have been published. Implementation of guidelines is challenging and most strategies have focused on changing physician behavior. Patient-based interventions have been shown to be effective in implementing guidelines on CHF but they have been very labor intensive. A computer based intervention to implement CHF guidelines, if effective, would be beneficial.

Interventions

  • BEHAVIORAL CHF Self-management Education (Web-based Education)

Trial Details

FieldValue
Enrollment Target 700 participants
Est. Completion 2004-03
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00013026 record still lists

NCT00013026 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower).

The record links to 0 conditions, and to 1 intervention - of which CHF Self-management Education (Web-based Education) is the first listed.

NCT00013026 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00013026 about?

NCT00013026 is a clinical study titled "Trial of a Tailored Message Program to Implement CHF Guidelines". Congestive heart failure is a serious health problem in the United States and is associated with excessive morbidity and mortality. Several classes of medications have been shown to improve mortality in patients with CHF. Despite this these medications are widely under prescribed. Guidelines have be...

What is the current status of trial NCT00013026?

This trial is currently completed. It is a NA study. The enrollment target is 700 participants. Estimated completion is 2004-03.

What interventions are being tested in trial NCT00013026?

The interventions under investigation include: CHF Self-management Education (Web-based Education) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00013026?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00013026's enrollment target sits among peer trials

700 149th of 2000 higher than 1,850 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900419 · 700 participants

    Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

  • NCT01804686 · 700 participants · Phase 3

    A Long-term Extension Study of PCI-32765 (Ibrutinib)

  • NCT02107989 · 700 participants

    Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

  • NCT02129543 · 700 participants

    Immune Reconstitution in Stem Cell Transplant Recipients

Source: ClinicalTrials.gov NCT00013026, the US trial registry maintained by the National Library of Medicine. NCT00013026 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.